Zika virus: from an obscurity to a priority

Microbes Infect. 2018 Dec;20(11-12):635-645. doi: 10.1016/j.micinf.2018.02.009. Epub 2018 Mar 9.

Abstract

Despite being discovered approximately 70 years ago, Zika virus (ZIKV) has received little attention, until the occurrence of alarming epidemics in the Pacific Islands and Latin America between 2013 and 2016. These series of outbreaks resulted in crippling neurological complications in adults, and congenital deformities in new-borns. The dire outcomes marked ZIKV as a re-emerging pathogen of public health concern. Over a period of two years, extensive studies have been conducted to understand different aspects of ZIKV from pathogen biology to infection, including the immune response during virus-host interplay in established animal models, as well as potential therapeutics against ZIKV infection. The vast diversity of novel findings has added value to ZIKV research, and a strategic consolidation is crucial to encompass the latest advances and developments, as well as missing pieces of the puzzle. This review thus aims to provide a concise yet extensive update on current ZIKV studies.

Keywords: Animal models; Immune responses; Therapeutics; Zika virus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • Antiviral Agents / therapeutic use*
  • Disease Models, Animal
  • Host-Pathogen Interactions
  • Humans
  • Immunity, Innate
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / immunology*
  • Zika Virus / pathogenicity
  • Zika Virus / physiology*
  • Zika Virus Infection / epidemiology
  • Zika Virus Infection / immunology*
  • Zika Virus Infection / prevention & control
  • Zika Virus Infection / therapy*

Substances

  • Antiviral Agents
  • Viral Vaccines